Tyra Biosciences
TYRA
26 hedge funds and large institutions have $457M invested in Tyra Biosciences in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
61.31% more ownership
Funds ownership: 0% → 61.31% (+61%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$138M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$121M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.5M |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$32.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$26.3M |
Top Sellers
TYRA Hedge Fund Activity: Q3 2021 in Review
26 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Tyra Biosciences (TYRA) for Q3 2021, worth a combined $457M.
Buyers outnumbered sellers: 26 funds opened new TYRA positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $138M.
- 26 institutional investors held Tyra Biosciences (TYRA) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $457M of Tyra Biosciences stock for Q3 2021.
- 26 funds opened new Tyra Biosciences positions in Q3 2021 and 0 closed out, a net change of +26 holders.
- The largest Tyra Biosciences buyer in Q3 2021 was RA Capital Management, an estimated $138M added.
Based on aggregated 13F filings for Q3 2021.